Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Rongyao Industrial Group is a China-based pharmaceutical group associated with the development, manufacture, and distribution of marketed drug products. Public company-profile sources describe the group as producing established small-molecule medicines including potassium penicillin capsules, amoxicillin capsules, ampicillin capsules, and acetaminophen tablets. Chinese business-registry sources also indicate that the current registered group entity functions as an industrial/investment holding company with external investments in affiliated businesses. Based on the available public information, the organization appears to be a commercial-stage pharmaceutical group rather than an R&D-focused biotech innovator. Detailed modern pipeline, clinical-stage, and partnership disclosures were not readily available in accessible public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Rongyao Industrial Group.